Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)

NCT00081328 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

699

Enrollment

NIH

Sponsor class

Conditions

Diabetes Mellitus, Type II

Interventions

DRUG: Metformin
DRUG: Rosiglitazone
BEHAVIORAL: Lifestyle Program

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)